Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George A Diamond

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Future Cardiology|October 7, 2009
Have the risks of rosiglitazone been exaggerated?Sanjay Kaul, George A Diamond
JACC. Cardiovascular Interventions|October 25, 2011
Should everolimus-eluting stents be preferred in patients with acute and stable coronary syndromes?Sanjay Kaul, George A Diamond
The American Heart Hospital Journal|August 4, 2007
Current status and future trends in drug-eluting stentsSanjay Kaul, George A Diamond
JAMA|October 16, 2008
The disconnect between practice guidelines and clinical practice--stressed outGeorge A Diamond, Sanjay Kaul
The American Journal of Cardiology|December 27, 2011
By desperate appliance relieved? On the clinical relevance of risk stratification to therapeutic decision-makingGeorge A Diamond, Sanjay Kaul
JACC. Cardiovascular Imaging|March 17, 2012
Improved prospects for IVUS in identifying vulnerable plaques?Sanjay Kaul, George A Diamond
Archives of Internal Medicine|June 30, 2010
Prasugrel and cancer: an uncertain association or a credible risk that meaningfully alters the benefit-risk balanceSanjay Kaul, George A Diamond
Nature Reviews. Cardiology|November 25, 2010
Diabetes: Breaking news! Rosiglitazone and cardiovascular riskSanjay Kaul, George A Diamond
Archives of Internal Medicine|August 12, 2009
Bayesian classification of clinical practice guidelinesGeorge A Diamond, Sanjay Kaul
Journal of the American College of Cardiology|June 3, 2004
Prior convictions: Bayesian approaches to the analysis and interpretation of clinical megatrialsGeorge A Diamond, Sanjay Kaul
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Future Cardiology|October 7, 2009
Have the risks of rosiglitazone been exaggerated?Sanjay Kaul, George A Diamond
JACC. Cardiovascular Interventions|October 25, 2011
Should everolimus-eluting stents be preferred in patients with acute and stable coronary syndromes?Sanjay Kaul, George A Diamond
The American Heart Hospital Journal|August 4, 2007
Current status and future trends in drug-eluting stentsSanjay Kaul, George A Diamond
JAMA|October 16, 2008
The disconnect between practice guidelines and clinical practice--stressed outGeorge A Diamond, Sanjay Kaul
The American Journal of Cardiology|December 27, 2011
By desperate appliance relieved? On the clinical relevance of risk stratification to therapeutic decision-makingGeorge A Diamond, Sanjay Kaul
JACC. Cardiovascular Imaging|March 17, 2012
Improved prospects for IVUS in identifying vulnerable plaques?Sanjay Kaul, George A Diamond
Archives of Internal Medicine|June 30, 2010
Prasugrel and cancer: an uncertain association or a credible risk that meaningfully alters the benefit-risk balanceSanjay Kaul, George A Diamond
Nature Reviews. Cardiology|November 25, 2010
Diabetes: Breaking news! Rosiglitazone and cardiovascular riskSanjay Kaul, George A Diamond
Archives of Internal Medicine|August 12, 2009
Bayesian classification of clinical practice guidelinesGeorge A Diamond, Sanjay Kaul
Journal of the American College of Cardiology|June 3, 2004
Prior convictions: Bayesian approaches to the analysis and interpretation of clinical megatrialsGeorge A Diamond, Sanjay Kaul
Pageof 6